News
60% Adults And 75% Kids Have COVID-19 Antibodies- CDC Study
According to updated information from the US Centers for Disease Control and Prevention, about 60% of adults plus 75% of children have antibodies suggesting...
News
Camzyos, A Likely Blockbuster Heart Drug, Wins FDA Approval
Bristol Myers Squibb has gained approval for one of the year's most anticipated medications, following a brief delay in November. Camzyos, a drug developed...
Press Releases
AARDEX Group adds etectRx to their MEMS Adherence Hardware ecosystem
Belgium-based AARDEX® Group, the leader in measuring and managing medication adherence in clinical trials announced a strategic partnership with etectRx, Inc. This new collaboration...
News
New programme celebrates ChargePoint Technology’s role in COVID-19 vaccine rollout
Specialist Merseyside manufacturing business ChargePoint Technology is set to appear in an ITN production exploring its role in helping to bring the first COVID-19...
Press Releases
Recipharm offers services to enable switch to next generation pMDI propellants
Global contract development and manufacturing organisation (CDMO) Recipharm, announces that it is expanding its pMDI product development expertise to accommodate the increasing demand from...
Press Releases
Peli BioThermal Adds New Service Centre in Baltimore
Peli BioThermal, the life science industry’s partner from discovery to distribution, announces its newest service centre located in Baltimore, Md. The Maryland facility joins...
News
Rinvoq, Blockbuster Drug From Abbvie Gets Fourth FDA Nod
The pharma version of Fast and Furious has a new superhero. How else to characterise AbbVie's Rinvoq's breakthrough effectiveness? The immunology medicine received its...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read